Surrozen, Inc. SRZNW
SRZNW
Surrozen, Inc. KTTA
Pasithea Therapeutics Corp. CERO
CERo Therapeutics Holdings, Inc. COEP
Coeptis Therapeutics, Inc. REVB
Revelation Biosciences, Inc. VINC
Vincerx Pharma, Inc. VRPX
Virpax Pharmaceuticals, Inc. NUVO
Holdco Nuvo Group D.G Ltd. Ordinary Shares NKGN
NKGen Biotech, Inc. Common Stock SYRS
Syros Pharmaceuticals, Inc.
Surrozen, Inc. KTTA
Pasithea Therapeutics Corp. CERO
CERo Therapeutics Holdings, Inc. COEP
Coeptis Therapeutics, Inc. REVB
Revelation Biosciences, Inc. VINC
Vincerx Pharma, Inc. VRPX
Virpax Pharmaceuticals, Inc. NUVO
Holdco Nuvo Group D.G Ltd. Ordinary Shares NKGN
NKGen Biotech, Inc. Common Stock SYRS
Syros Pharmaceuticals, Inc.
Performance
| Periode | SRZNW | KTTA | CERO | COEP | REVB | VINC | VRPX | NUVO | NKGN | SYRS |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 38.67 % | 32.11 % | -99.48 % | 29.55 % | -68.05 % | -72.92 % | -97.38 % | 4 494.59 % | -76.92 % | -92.59 % |
| YTD | -5.45 % | -22.21 % | -35.07 % | -13.46 % | 16.70 % | 0.00 % | 0.00 % | 8 400.00 % | 20.00 % | 0.00 % |
| 1Y | -46.67 % | -62.22 % | -99.91 % | 32.53 % | -95.23 % | -99.54 % | -99.86 % | 8 400.00 % | -86.97 % | -99.90 % |
| 3Y | -68.00 % | -93.57 % | -100.00 % | -66.83 % | -99.99 % | -99.94 % | -99.99 % | -97.54 % | -98.95 % | -100.00 % |
| 5Y | -99.06 % | -98.70 % | -100.00 % | -93.80 % | -100.00 % | -100.00 % | -100.00 % | -97.54 % | -98.95 % | -100.00 % |
| 10Y | -98.88 % | -98.70 % | -100.00 % | -93.60 % | -100.00 % | -99.99 % | -100.00 % | -97.54 % | -98.95 % | -100.00 % |
| From the beginning | -98.88 % | -98.70 % | -100.00 % | -93.60 % | -100.00 % | -99.99 % | -100.00 % | -97.54 % | -98.95 % | -100.00 % |